Intralipid Infusion

What is it?

Intralipid is a fat emulsion solution that consists of soybean oil, egg yolk phospholipids and glycerine. Research in both animals and humans has shown that Intralipid may enhance implantation and maintenance of pregnancy.

Natural Killer (NK) cells are regulated by the immune system. In women who have autoimmune issues, the NK cells can react abnormally to an implanting embryo, treating it has an invading cell and signalling for the body to attack it. Studies have found that Intralipid can help regulate the NK cells, allowing the embryo to implant on the uterine wall and grow normally.

Intralipid is given as an intravenous infusion. You will be required to have some blood tests performed and sign a Consent Form prior to the infusion. As recommended by your PIVET doctor, Intralipid is scheduled 10-14 days prior to embryo transfer, and a second infusion around the day of “trigger” for IVF patients and before embryo transfer for FET patients.

Who is it suitable for?

Intralipid infusion is suitable for patients who experience recurrent implantation failure and recurrent pregnancy loss.

Please contact PIVET Medical Centre for further information.

Download our treatment cycle handbook